Sort
261,768 grants matching “gene therapy”
Microphysiological systems for modeling autoimmunity in type 1 diabetes
$1,124,415Ben Z Stanger · University Of Pennsylvania · UH3 · FY2022 · DK
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,124,257Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Preclinical evaluation of a potent Lassa fever immunotherapeutic antibody cocktail
$1,124,215Robert F Garry · Tulane University Of Louisiana · R01 · FY2021 · AI
A "Trojan Horse" bispecific antibody strategy for broad filovirus therapeutics
$1,124,111Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2019 · AI
SPORE in Prostate Cancer
$1,124,001Michael M. Ittmann · Baylor College Of Medicine · P50 · FY2007 · CA
From genetic association to function: pleiotropic novel genes and variants linking lipid metabolism and cardiovascular diseases
$1,123,889Daniel James Rader · University Of Pennsylvania · R35 · FY2024 · HL
Novel Neuroprotective/Restorative Therapy for Ischemic Stroke
$1,123,879David E Smith · Angion Biomedica Corporation · R44 · FY2009 · NS
Factors Influencing Genetic Transcription Initiation And Termination
$1,123,757Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease
$1,123,674George A Truskey · Duke University · UH3 · FY2019 · TR
Neurosurgical Oncology Unit
$1,123,670Desmond Brown · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
PA-50/PA-41 antitoxin antibody therapy for C. difficile infection
$1,123,669William C Olson · Progenics Pharmaceuticals, Inc. · R01 · FY2011 · AI
Developmental Mechanisms of Human Idiopathic Scoliosis
$1,123,586Carol A Wise · Ut Southwestern Medical Center · P01 · FY2019 · HD
Developmental Mechanisms of Human Idiopathic Scoliosis
$1,123,586Carol A Wise · Ut Southwestern Medical Center · P01 · FY2020 · HD
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
$1,123,564Rachel Saunders-Pullman · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · NS
Human genetic supplementation without donor DNA or a DNA break
$1,123,500Kathleen Collins · University Of California Berkeley · DP1 · FY2024 · HL
Human genetic supplementation without donor DNA or a DNA break
$1,123,500Kathleen Collins · University Of California Berkeley · DP1 · FY2022 · HL
Human genetic supplementation without donor DNA or a DNA break
$1,123,500Kathleen Collins · University Of California Berkeley · DP1 · FY2021 · HL
Human genetic supplementation without donor DNA or a DNA break
$1,123,500Kathleen Collins · University Of California Berkeley · DP1 · FY2023 · HL
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists
$1,123,370Steven Daniel Douglas · Children'S Hosp Of Philadelphia · U01 · FY2012 · MH
CANCER AND INFLAMMATION GENETICS
$1,123,302Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Cellular and Molecular Pathways for Hearing Restoration in the Adult Inner Ear
$1,123,159Michael Hoa · National Institute On Deafness And Other Communication Disorders · ZIA · FY2020 · DC
Defining the resistome in P. falciparum: evolution and mechanism
$1,123,100Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2025 · AI
Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases
$1,122,968Daniel Kastner · National Human Genome Research Institute · ZIA · FY2012 · HG
Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases
$1,122,968Daniel Kastner · National Human Genome Research Institute · ZIA · FY2012 · HG
Pediatric Oncology Branch Behavioral Science Core
$1,122,874John Glod · Division Of Basic Sciences - Nci · ZID · FY2021 · CA